3 hours Genmab A/S (NASDAQ:GMAB) Coverage Initiated by Analysts at Redburn Atlantic MarketBeat
Redburn Atlantic assumed coverage on shares of Genmab A/S in a research report on Tuesday. They set a “buy” rating for the company.
Redburn Atlantic assumed coverage on shares of Genmab A/S in a research report on Tuesday. They set a “buy” rating for the company.